Molineaux Christopher P.

CIK 00016547731 companyWAYNE, PA

SEC Profile

Transactions

Companies

Filings

CIK

0001654773

Recent Transactions

48 trades

Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2025-06-06+4,793→ 57,956 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2025-06-06−4,793→ 0 total
Award
Aclaris Therapeutics, Inc.$ACRS
Stock Option (Right to Buy)
2025-06-05+42,350→ 42,350 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2025-06-05+11,580→ 11,580 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2024-06-06+4,793→ 4,793 total
Award
Aclaris Therapeutics, Inc.$ACRS
Stock Option (Right to Buy)
2024-06-06+15,750→ 15,750 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2024-06-01+4,660→ 53,163 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2024-06-01−4,660→ 0 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2023-06-20$1.41/sh+16,500→ 48,503 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Stock Option (right to buy)
2023-06-20−16,500→ 0 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Stock Option (right to buy)
2023-06-15−198→ 0 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2023-06-15$1.52/sh+198→ 32,003 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Stock Option (right to buy)
2023-06-15−51→ 0 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2023-06-15$0.72/sh+51→ 31,805 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2023-06-02−4,507→ 0 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2023-06-02+4,507→ 31,754 total
Award
Aclaris Therapeutics, Inc.$ACRS
Stock Option (Right to Buy)
2023-06-01+15,750→ 15,750 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2023-06-01+4,660→ 4,660 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2022-06-03−3,356→ 0 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2022-06-03+3,356→ 27,247 total
Award
Aclaris Therapeutics, Inc.$ACRS
Stock Option (Right to Buy)
2022-06-02+15,750→ 15,750 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2022-06-02+4,507→ 4,507 total
Award
Aclaris Therapeutics, Inc.$ACRS
Stock Option (Right to Buy)
2021-06-03+12,250→ 12,250 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2021-06-03+3,356→ 3,356 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2020-06-06−7,333→ 0 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2020-06-06+7,333→ 23,891 total
Award
Aclaris Therapeutics, Inc.$ACRS
Option Grant (right to buy)
2020-06-04+16,500→ 16,500 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted stock units
2020-03-02+8,876→ 8,876 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2020-03-02+8,876→ 16,558 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted stock units
2020-03-02−8,876→ 0 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2019-06-06+7,333→ 7,333 total
Award
Aclaris Therapeutics, Inc.$ACRS
Stock Option (right to buy)
2018-06-07+8,000→ 8,000 total
Sale
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2018-04-06$16.52/sh+2,300→ 7,682 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Stock option (right to buy)
2018-03-20−120→ 51 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Stock option (right to buy)
2018-03-20−264→ 198 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2018-03-20$0.72/sh+120→ 9,718 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2018-03-20$1.52/sh+264→ 9,982 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Stock option (right to buy)
2018-03-20−1,993→ 0 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2018-03-20$0.41/sh+1,993→ 9,598 total
Award
Aclaris Therapeutics, Inc.$ACRS
Stock Option (right to buy)
2017-06-15+8,000→ 8,000 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Stock option (right to buy)
2017-03-17−6,702→ 1,993 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2017-03-17$0.41/sh+6,702→ 6,702 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Stock option (right to buy)
2017-03-17−311→ 171 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2017-03-17$1.52/sh+592→ 7,294 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Stock option (right to buy)
2017-03-17−592→ 462 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2017-03-17$0.72/sh+311→ 7,605 total
Award
Aclaris Therapeutics, Inc.$ACRS
Stock Option (right to buy)
2016-06-29+6,632→ 6,632 total
Award
Aclaris Therapeutics, Inc.$ACRS
Stock option (right to buy)
2015-12-18+2,759→ 2,759 total

Companies

Aclaris Therapeutics, Inc.
Director
$ACRS

Recent Filings

Address

C/O ACLARIS THERAPEUTICS, INC. 701 LEE ROAD, SUITE 103

WAYNE, PA, 19087

View on SEC.gov